Vivoryon Therapeutics N.V. Stock
Vivoryon Therapeutics N.V. dominated the market today, gaining €0.057 (7.430%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vivoryon Therapeutics N.V. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vivoryon Therapeutics N.V. in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vivoryon Therapeutics N.V. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vivoryon Therapeutics N.V. | 7.430% | 26.133% | 58.144% | -95.696% | -89.614% | -94.241% | -96.107% |
| CytoTools AG | -1.900% | -32.963% | 9.697% | -83.084% | -52.987% | -97.955% | -97.057% |
| Nanorepro AG | -1.920% | -0.551% | 3.143% | -15.654% | -12.379% | -79.036% | 56.957% |
| Heidelberg Pharma AG | 4.590% | 2.310% | 0.000% | -22.500% | -15.761% | -53.523% | 0.000% |